EMEA (Europe, Middle East and Africa) Blood Glucose Device Market Report 2017

December 2017 | 106 pages | ID: E112D3804A5EN
QYResearch

Abstracts

In this report, the EMEA Blood Glucose Device market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Blood Glucose Device for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Blood Glucose Device market competition by top manufacturers/players, with Blood Glucose Device sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abbott Laboratories (U.S.)
• ARKRAY (Japan)
• Dexcom (U.S.)
• F.Hoffmann-La Roche Ltd (Switzerland)
• Johnson & Johnson (U.S.)
• Medtronic (U.S.)
• Nipro Diagnostics (U.S.)
• Terumo Medical Corporation (U.S.)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• By Product
• Blood Glucose Monitors
• Glucose Monitoring Strips
• Lancets
• By Type
• Single Point Blood Glucose Meters
• Continuous Glucose Monitoring Systems

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Diagnostics
• Home Settings
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Blood Glucose Device Market Report 2017

1 BLOOD GLUCOSE DEVICE OVERVIEW

1.1 Product Overview and Scope of Blood Glucose Device
1.2 Classification of Blood Glucose Device
  1.2.1 EMEA Blood Glucose Device Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Blood Glucose Device Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Blood Glucose Monitors
  1.2.4 Glucose Monitoring Strips
  1.2.5 Lancets
1.3 EMEA Blood Glucose Device Market by Application/End Users
  1.3.1 EMEA Blood Glucose Device Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Diagnostics
  1.3.4 Home Settings
  1.3.5 Others
1.4 EMEA Blood Glucose Device Market by Region
  1.4.1 EMEA Blood Glucose Device Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Blood Glucose Device (2012-2022)
  1.5.1 EMEA Blood Glucose Device Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Blood Glucose Device Revenue and Growth Rate (2012-2022)

2 EMEA BLOOD GLUCOSE DEVICE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Blood Glucose Device Market Competition by Players/Manufacturers
  2.1.1 EMEA Blood Glucose Device Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Blood Glucose Device Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Blood Glucose Device Sale Price by Players (2012-2017)
2.2 EMEA Blood Glucose Device (Volume and Value) by Type/Product Category
  2.2.1 EMEA Blood Glucose Device Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Blood Glucose Device Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Blood Glucose Device Sale Price by Type (2012-2017)
2.3 EMEA Blood Glucose Device (Volume) by Application
2.4 EMEA Blood Glucose Device (Volume and Value) by Region
  2.4.1 EMEA Blood Glucose Device Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Blood Glucose Device Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Blood Glucose Device Sales Price by Region (2012-2017)

3 EUROPE BLOOD GLUCOSE DEVICE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Blood Glucose Device Sales and Value (2012-2017)
  3.1.1 Europe Blood Glucose Device Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Blood Glucose Device Revenue and Growth Rate (2012-2017)
3.2 Europe Blood Glucose Device Sales and Market Share by Type
3.3 Europe Blood Glucose Device Sales and Market Share by Application
3.4 Europe Blood Glucose Device Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Blood Glucose Device Sales Volume by Countries (2012-2017)
  3.4.2 Europe Blood Glucose Device Revenue by Countries (2012-2017)
  3.4.3 Germany Blood Glucose Device Sales and Growth Rate (2012-2017)
  3.4.4 France Blood Glucose Device Sales and Growth Rate (2012-2017)
  3.4.5 UK Blood Glucose Device Sales and Growth Rate (2012-2017)
  3.4.6 Russia Blood Glucose Device Sales and Growth Rate (2012-2017)
  3.4.7 Italy Blood Glucose Device Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Blood Glucose Device Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BLOOD GLUCOSE DEVICE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Blood Glucose Device Sales and Value (2012-2017)
  4.1.1 Middle East Blood Glucose Device Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Blood Glucose Device Revenue and Growth Rate (2012-2017)
4.2 Middle East Blood Glucose Device Sales and Market Share by Type
4.3 Middle East Blood Glucose Device Sales and Market Share by Application
4.4 Middle East Blood Glucose Device Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Blood Glucose Device Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Blood Glucose Device Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Blood Glucose Device Sales and Growth Rate (2012-2017)
  4.4.4 Israel Blood Glucose Device Sales and Growth Rate (2012-2017)
  4.4.5 UAE Blood Glucose Device Sales and Growth Rate (2012-2017)
  4.4.6 Iran Blood Glucose Device Sales and Growth Rate (2012-2017)

5 AFRICA BLOOD GLUCOSE DEVICE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Blood Glucose Device Sales and Value (2012-2017)
  5.1.1 Africa Blood Glucose Device Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Blood Glucose Device Revenue and Growth Rate (2012-2017)
5.2 Africa Blood Glucose Device Sales and Market Share by Type
5.3 Africa Blood Glucose Device Sales and Market Share by Application
5.4 Africa Blood Glucose Device Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Blood Glucose Device Sales Volume by Countries (2012-2017)
  5.4.2 Africa Blood Glucose Device Revenue by Countries (2012-2017)
  5.4.3 South Africa Blood Glucose Device Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Blood Glucose Device Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Blood Glucose Device Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Blood Glucose Device Sales and Growth Rate (2012-2017)

6 EMEA BLOOD GLUCOSE DEVICE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abbott Laboratories (U.S.)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Blood Glucose Device Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 ARKRAY (Japan)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Blood Glucose Device Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Dexcom (U.S.)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Blood Glucose Device Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F.Hoffmann-La Roche Ltd (Switzerland)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Blood Glucose Device Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson (U.S.)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Blood Glucose Device Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Medtronic (U.S.)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Blood Glucose Device Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Nipro Diagnostics (U.S.)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Blood Glucose Device Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Terumo Medical Corporation (U.S.)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Blood Glucose Device Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 BLOOD GLUCOSE DEVICE MANUFACTURING COST ANALYSIS

7.1 Blood Glucose Device Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Blood Glucose Device

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Blood Glucose Device Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Blood Glucose Device Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BLOOD GLUCOSE DEVICE MARKET FORECAST (2017-2022)

11.1 EMEA Blood Glucose Device Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Blood Glucose Device Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Blood Glucose Device Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Blood Glucose Device Price and Trend Forecast (2017-2022)
11.2 EMEA Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Blood Glucose Device Sales Forecast by Type (2017-2022)
11.7 EMEA Blood Glucose Device Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Blood Glucose Device
Figure EMEA Blood Glucose Device Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Blood Glucose Device Sales Volume Market Share by Type (Product Category) in 2016
Figure Blood Glucose Monitors Product Picture
Figure Glucose Monitoring Strips Product Picture
Figure Lancets Product Picture
Figure EMEA Blood Glucose Device Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Blood Glucose Device by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostics Examples
Table Key Downstream Customer in Diagnostics
Figure Home Settings Examples
Table Key Downstream Customer in Home Settings
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Blood Glucose Device Market Size (Million USD) by Region (2012-2022)
Figure Europe Blood Glucose Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Blood Glucose Device Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Blood Glucose Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Blood Glucose Device Revenue (Million USD) Status and Forecast by Countries
Figure Africa Blood Glucose Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Blood Glucose Device Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Blood Glucose Device Sales Volume and Growth Rate (2012-2022)
Figure EMEA Blood Glucose Device Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Blood Glucose Device Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Blood Glucose Device Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Blood Glucose Device Sales Share by Players (2012-2017)
Figure 2016 Blood Glucose Device Sales Share by Players
Figure 2017 Blood Glucose Device Sales Share by Players
Figure EMEA Blood Glucose Device Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Blood Glucose Device Revenue (Million USD) by Players (2012-2017)
Table EMEA Blood Glucose Device Revenue Share by Players (2012-2017)
Table 2016 EMEA Blood Glucose Device Revenue Share by Players
Table 2017 EMEA Blood Glucose Device Revenue Share by Players
Table EMEA Blood Glucose Device Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Blood Glucose Device Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Blood Glucose Device Sales Share by Type (2012-2017)
Figure Sales Market Share of Blood Glucose Device by Type (2012-2017)
Figure EMEA Blood Glucose Device Sales Market Share by Type (2012-2017)
Table EMEA Blood Glucose Device Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Blood Glucose Device Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Blood Glucose Device by Type in 2016
Table EMEA Blood Glucose Device Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Blood Glucose Device Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Blood Glucose Device Sales Share by Application (2012-2017)
Figure Sales Market Share of Blood Glucose Device by Application (2012-2017)
Figure EMEA Blood Glucose Device Sales Market Share by Application in 2016
Table EMEA Blood Glucose Device Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Blood Glucose Device Sales Share by Region (2012-2017)
Figure Sales Market Share of Blood Glucose Device by Region (2012-2017)
Figure EMEA Blood Glucose Device Sales Market Share in 2016
Table EMEA Blood Glucose Device Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Blood Glucose Device Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Blood Glucose Device by Region (2012-2017)
Figure EMEA Blood Glucose Device Revenue Market Share Regions in 2016
Table EMEA Blood Glucose Device Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Blood Glucose Device Revenue and Growth Rate (2012-2017)
Table Europe Blood Glucose Device Sales (K Units) by Type (2012-2017)
Table Europe Blood Glucose Device Market Share by Type (2012-2017)
Figure Europe Blood Glucose Device Market Share by Type in 2016
Table Europe Blood Glucose Device Sales (K Units) by Application (2012-2017)
Table Europe Blood Glucose Device Market Share by Application (2012-2017)
Figure Europe Blood Glucose Device Market Share by Application in 2016
Table Europe Blood Glucose Device Sales (K Units) by Countries (2012-2017)
Table Europe Blood Glucose Device Sales Market Share by Countries (2012-2017)
Figure Europe Blood Glucose Device Sales Market Share by Countries (2012-2017)
Figure Europe Blood Glucose Device Sales Market Share by Countries in 2016
Table Europe Blood Glucose Device Revenue (Million USD) by Countries (2012-2017)
Table Europe Blood Glucose Device Revenue Market Share by Countries (2012-2017)
Figure Europe Blood Glucose Device Revenue Market Share by Countries (2012-2017)
Figure Europe Blood Glucose Device Revenue Market Share by Countries in 2016
Figure Germany Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure France Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure UK Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Blood Glucose Device Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Blood Glucose Device Sales (K Units) by Type (2012-2017)
Table Middle East Blood Glucose Device Market Share by Type (2012-2017)
Figure Middle East Blood Glucose Device Market Share by Type (2012-2017)
Table Middle East Blood Glucose Device Sales (K Units) by Applications (2012-2017)
Table Middle East Blood Glucose Device Market Share by Applications (2012-2017)
Figure Middle East Blood Glucose Device Sales Market Share by Application in 2016
Table Middle East Blood Glucose Device Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Blood Glucose Device Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Blood Glucose Device Sales Volume Market Share by Countries in 2016
Table Middle East Blood Glucose Device Revenue (Million USD) by Countries (2012-2017)
Table Middle East Blood Glucose Device Revenue Market Share by Countries (2012-2017)
Figure Middle East Blood Glucose Device Revenue Market Share by Countries (2012-2017)
Figure Middle East Blood Glucose Device Revenue Market Share by Countries in 2016
Figure Saudi Arabia Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Blood Glucose Device Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Blood Glucose Device Sales (K Units) by Type (2012-2017)
Table Africa Blood Glucose Device Sales Market Share by Type (2012-2017)
Figure Africa Blood Glucose Device Sales Market Share by Type (2012-2017)
Figure Africa Blood Glucose Device Sales Market Share by Type in 2016
Table Africa Blood Glucose Device Sales (K Units) by Application (2012-2017)
Table Africa Blood Glucose Device Sales Market Share by Application (2012-2017)
Figure Africa Blood Glucose Device Sales Market Share by Application (2012-2017)
Table Africa Blood Glucose Device Sales Volume (K Units) by Countries (2012-2017)
Table Africa Blood Glucose Device Sales Market Share by Countries (2012-2017)
Figure Africa Blood Glucose Device Sales Market Share by Countries (2012-2017)
Figure Africa Blood Glucose Device Sales Market Share by Countries in 2016
Table Africa Blood Glucose Device Revenue (Million USD) by Countries (2012-2017)
Table Africa Blood Glucose Device Revenue Market Share by Countries (2012-2017)
Figure Africa Blood Glucose Device Revenue Market Share by Countries (2012-2017)
Figure Africa Blood Glucose Device Revenue Market Share by Countries in 2016
Figure South Africa Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Table Abbott Laboratories (U.S.) Blood Glucose Device Basic Information List
Table Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories (U.S.) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories (U.S.) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table ARKRAY (Japan) Blood Glucose Device Basic Information List
Table ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ARKRAY (Japan) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure ARKRAY (Japan) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure ARKRAY (Japan) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table Dexcom (U.S.) Blood Glucose Device Basic Information List
Table Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dexcom (U.S.) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Dexcom (U.S.) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure Dexcom (U.S.) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Basic Information List
Table F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson (U.S.) Blood Glucose Device Basic Information List
Table Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson (U.S.) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson (U.S.) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table Medtronic (U.S.) Blood Glucose Device Basic Information List
Table Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic (U.S.) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic (U.S.) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure Medtronic (U.S.) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table Nipro Diagnostics (U.S.) Blood Glucose Device Basic Information List
Table Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Nipro Diagnostics (U.S.) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure Nipro Diagnostics (U.S.) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table Terumo Medical Corporation (U.S.) Blood Glucose Device Basic Information List
Table Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units) and Growth Rate (2012-2017)
Figure Terumo Medical Corporation (U.S.) Blood Glucose Device Sales Market Share in EMEA (2012-2017)
Figure Terumo Medical Corporation (U.S.) Blood Glucose Device Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Blood Glucose Device
Figure Manufacturing Process Analysis of Blood Glucose Device
Figure Blood Glucose Device Industrial Chain Analysis
Table Raw Materials Sources of Blood Glucose Device Major Manufacturers in 2016
Table Major Buyers of Blood Glucose Device
Table Distributors/Traders List
Figure EMEA Blood Glucose Device Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Blood Glucose Device Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Blood Glucose Device Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Blood Glucose Device Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Blood Glucose Device Sales Market Share Forecast by Region (2017-2022)
Table EMEA Blood Glucose Device Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Blood Glucose Device Revenue Market Share Forecast by Region (2017-2022)
Table Europe Blood Glucose Device Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Blood Glucose Device Sales Market Share Forecast by Countries (2017-2022)
Table Europe Blood Glucose Device Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Blood Glucose Device Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Blood Glucose Device Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Blood Glucose Device Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Blood Glucose Device Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Blood Glucose Device Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Blood Glucose Device Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Blood Glucose Device Sales Market Share Forecast by Countries (2017-2022)
Table Africa Blood Glucose Device Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Blood Glucose Device Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Blood Glucose Device Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Blood Glucose Device Sales Market Share Forecast by Type (2017-2022)
Table EMEA Blood Glucose Device Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Blood Glucose Device Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources